51 results on '"Saelens, Xavier"'
Search Results
2. Clonotypic analysis of protective influenza M2e-specific lung resident Th17 memory cells reveals extensive functional diversity
3. ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection
4. The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration
5. mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice
6. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
7. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
8. Next-Generation Sequencing: An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza
9. Walter Fiers (1931–2019)
10. New antibody-based prevention and treatment options for influenza
11. Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses
12. A two-amino acid mutation in murine IgA enables downstream processing and purification on staphylococcal superantigen-like protein 7
13. Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice
14. Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy
15. Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist
16. Vaccine options for influenza: thinking small
17. Clinical Potential of Prefusion RSV F-specific Antibodies
18. Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus
19. Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection
20. IgG3 Snitcher of RSV Infections in the Very Young
21. Chemical-controlled Activation of Antiviral Myxovirus Resistance Protein 1
22. Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses
23. Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages
24. GM-CSF treatment prevents respiratory syncytial virus–induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation
25. One Against All: A Broadly Influenza Neutralizing Man-made Monoclonal Antibody Passes Phase I
26. Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine
27. ID: 208
28. Sequence-dependent Internalization of Aggregating Peptides
29. CD8+ T cell immunity against human respiratory syncytial virus
30. Challenges and advances towards the rational design of mRNA vaccines
31. Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection
32. Nanobodies®: New ammunition to battle viruses
33. A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus
34. Role of IFN-α during the acute stage of a swine influenza virus infection
35. M2e-based universal influenza A vaccine
36. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies
37. An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2
38. CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine
39. Improved design and intranasal delivery of an M2e-based human influenza A vaccine
40. Necrosis is associated with IL-6 production but apoptosis is not
41. The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection
42. A Novel Caspase-2 Complex Containing TRAF2 and RIP1
43. INCA, a Novel Human Caspase Recruitment Domain Protein That Inhibits Interleukin-1β Generation
44. Caspase-1 Activates Nuclear Factor of the κ-Enhancer in B Cells Independently of Its Enzymatic Activity
45. Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing
46. Differential Signaling to Apoptotic and Necrotic Cell Death by Fas-associated Death Domain Protein FADD
47. Proteolysis of Enteric Cell Villin by Entamoeba histolytica Cysteine Proteinases
48. A Bcl-2 transgene expressed in hepatocytes does not protect mice from fulminant liver destruction induced by Fas ligand
49. Mitochondrial intermembrane proteins in cell death
50. Translation Inhibition in Apoptosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.